Radiation recall myositis: two sites, one patient

Pract Radiat Oncol. 2015 Jan-Feb;5(1):39-42. doi: 10.1016/j.prro.2014.03.009. Epub 2014 May 5.

Authors

Surbhi Grover¹, Joshua A Jones², Ursina Teitelbaum³, Smith Apisarnthanarax⁴

Affiliations

¹ Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: surbhi.grover@uphs.upenn.edu.
² Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
³ Department of Medicine, Division of Medical Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
⁴ Department of Radiation Oncology, University of Washington, Seattle, Washington.

PMID: 25413426
DOI: 10.1016/j.prro.2014.03.009

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma / drug therapy
Adenocarcinoma / radiotherapy
Adenocarcinoma of Lung
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carboplatin / administration & dosage
Carboplatin / adverse effects
Deoxycytidine / administration & dosage
Deoxycytidine / adverse effects
Deoxycytidine / analogs & derivatives
Gemcitabine
Humans
Lung Neoplasms / drug therapy
Lung Neoplasms / radiotherapy
Magnetic Resonance Imaging
Male
Middle Aged
Myositis / etiology*
Neoplasms, Unknown Primary / drug therapy
Neoplasms, Unknown Primary / radiotherapy
Neuroendocrine Tumors / drug therapy
Neuroendocrine Tumors / radiotherapy
Pancreatic Neoplasms / drug therapy
Pancreatic Neoplasms / radiotherapy
Radiation Injuries / etiology*

Substances

Deoxycytidine
Carboplatin
Gemcitabine